48,450 Shares in Azenta, Inc. $AZTA Acquired by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. bought a new stake in shares of Azenta, Inc. (NASDAQ:AZTA – Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 48,450 shares of the company’s stock, valued at approximately $1,690,000. Jefferies Financial Group Inc. owned about 0.11% of Azenta at the end of the most recent quarter.

Several other institutional investors also recently made changes to their positions in the stock. Legal & General Group Plc acquired a new position in Azenta during the 2nd quarter valued at approximately $2,453,000. Hsbc Holdings PLC acquired a new stake in Azenta in the second quarter worth $1,108,000. Jupiter Topco LLC acquired a new stake in Azenta in the second quarter worth $435,000. Man Group plc acquired a new stake in Azenta in the second quarter worth $9,402,000. Finally, Bank of America Corp DE bought a new stake in Azenta in the second quarter valued at $17,058,000. 99.08% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on AZTA shares. Jefferies Financial Group boosted their price target on shares of Azenta from $44.00 to $52.00 and gave the company a “buy” rating in a report on Wednesday, November 11th. Needham & Company LLC upped their price target on shares of Azenta from $37.00 to $57.00 and gave the stock a “buy” rating in a research report on Wednesday, November 11th. Zacks Research began coverage on shares of Azenta in a report on Thursday. They issued a “hold” rating on the stock. Wall Street Zen upgraded shares of Azenta from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Weiss Ratings upgraded shares of Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, August 26th. Four equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $47.60.

Get Our Latest Stock Report on Azenta

More Azenta News

These are some of the AZTA news items that stood out recently:

  • Positive Sentiment: Better-than-expected quarterly results helped fuel buying: Azenta reported earnings of $0.28 per share versus analysts’ $0.11 estimate, and revenue of $167.1 million, above the $160.2 million consensus. Shares subsequently reached a 52-week high. Article: Azenta Reaches New 52-Week High Following Better-Than-Expected Earnings
  • Positive Sentiment: Needham raised its price target to $57 from $37 and maintained a Buy rating, signaling greater optimism about potential upside. Article: Needham Raises Azenta Price Target
  • Negative Sentiment: Rosen Law Firm said it is investigating potential securities claims tied to allegations that Azenta may have issued materially misleading business information. The investigation is an allegation, not a finding of wrongdoing, but may weigh on sentiment. Article: Rosen Law Firm Investor Notice

Azenta Stock Performance

Shares of AZTA stock opened at $45.65 on Monday. Azenta, Inc. has a 1 year low of $15.93 and a 1 year high of $50.06. The firm has a market capitalization of $2.00 billion, a PE ratio of -12.61 and a beta of 1.47. The stock has a fifty day moving average of $36.52 and a two-hundred day moving average of $28.56.

Azenta (NASDAQ:AZTA – Get Free Report) last issued its quarterly earnings results on Tuesday, November 10th. The company reported $0.28 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.17. Azenta had a positive return on equity of 1.41% and a negative net margin of 26.86%. The company had revenue of $167.09 million for the quarter, compared to analyst estimates of $160.16 million. Equities research analysts predict that Azenta, Inc. will post 0.69 earnings per share for the current fiscal year.

About Azenta

(Free Report)

Azenta, Inc. provides products and services for life sciences research and the management of biological samples. Its offerings include automated sample storage systems, laboratory automation equipment, consumables, and software used to track and manage samples. The company also provides genomic services through GENEWIZ, including sequencing and other genetic analysis services for researchers and organizations in the life sciences and pharmaceutical industries. Azenta was formed in 2021 when Brooks Automation separated its life sciences business and adopted the Azenta name.

Further Reading

Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA – Free Report).

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.